Condition 1: Infertility. Condition 2: Endometriosis preparation for freezing embryo transfer. Female infertility complication associated with artificial fertilization ,unspecified
Conditions
Interventions
Intervention 1: Intervention group: Twenty-one Cinafact units a day from progesterone onset will be given to the patient from Mid luteal phase and continue the same way and then from the second day of
Sponsors
Sarem Fertility and Infertility Research Center
Eligibility
Sex/Gender
Female
Age
25 Years to 40 Years
Inclusion criteria
Inclusion criteria: Have at least two embryos for transfer. The embryo has been removed from the freeze after thawing and has grade A quality. Absence of internal uterine anomalies such as adenomyosis and uterine fibroids and uterine malformations Absence of clear endometrioma Patients who used the agonist protocol in the ICSI cycle. Absence of systemic diseases (such as collagen, vascular disease, chronic hypertension, diabetes: a well-known case of diabetes with a fasting FBS of over 126) Vitamin D should be modified before starting ICSI. Age range from 25 to 40 years.
Exclusion criteria
Exclusion criteria: Determine endometrioma during FET.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: Day 14 after transfer. Method of measurement: laboratory tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Farahnaz Zandi
Sarem Fertility and Infertility Research Center
Outcome results
None listed